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Abstract: Nutrition status plays a critical role in pressure injury (PI) healing and yet the available literature,
especially in pediatric patients, is limited. Critically ill pediatric patients are at an increased risk of skin
integrity compromise and PI development. Adequate nutritional intake can often be challenging to achieve
in this population and immobility and illness present additional obstacles to maintaining skin integrity in
this vulnerable population. Despite the unique nutritional challenges and needs of this group, there is no
standardized approach to macro- and micronutrient management and monitoring. Here, several key vitamins
and minerals believed to play a role in PI healing are discussed and an approach to nutritional management
and monitoring for PI healing in pediatric patients is proposed. Registered dietitians (RD) are essential to
assess individual patient macro and micronutrient requirements, to identify gaps and make recommendations
to optimize nutritional therapy that may exist and impact wound healing. We used a scoping review to focus
on the interplay of nutrition and PI healing and inform a multidisciplinary approach to PI identification
and management. Through this review, we propose a strategy for the nutritional management of pediatric
patients <30 kg at risk for and who present with PI.
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Introduction

and function require macro and micronutrients for cell

The skin is the largest organ system whose primary
function is to serve as a barrier to protect the body against
foreign microbes and noxious substances. Skin integrity

turnover to maintain homeostasis, and support new
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growth, and repair, especially in the event of injury or
decreased integrity. Immobility, illness, or injury coupled
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with risk of suboptimal nutrient intake put the skin at risk
for compromise, particularly in hospitalized infants and
children, a population that presents unique challenges
for nutrition therapy and optimal skin care. In addition
to providing for the metabolic demands of their current
disease, illness or injury, nutrition therapy must also address
any pre-existing malnutrition, minimize any deterioration
of nutrition status and growth milestones.
A common compromise of skin barrier in hospitalized
children is the occurrence of a pressure injury (PI).
Defined in terms of the localization of injury to skin or
underlying tissue singularly imputable to pressure or a
combination of pressure and skin shear (1), the incidence of
PI (expressed as the number of PI per 1,000 patient days)
in children reportedly ranges between 10% to 27% (2,3).
The prevalence of PI (number of patients affected / total
patient population at a given point in time) in children is
reported to be as high as 43% (1). In hospitalized patients,
the combined prevalence and incidence of PI define its
occurrence [per patient days, or per device days in the case
of medical device related pressure injury (MDRPI)]. In a
series of three prevalence surveys of hospital acquired skin
injury (HASI), Stellar et al. (2013) report PI to be the most
common type of skin injury in children (4). The etiology
of these injuries includes immobility, MDRPI, diaper
dermatitis and epidermal stripping. Overall, current data
suggests that 1.4% of all infants and children experience a
PI during hospitalization (1,5).
Skin compromise can be categorized into two broad
groups—those caused by intrinsic factors and those due to
extrinsic causes, both of which can result in a PI. Intrinsic
factors may be the underlying disease entity, including
autoimmune and genetic conditions, immune compromised
status, conditions requiring surgical intervention, moisture
associated skin disruption and skin breakdown associated
with medication or therapeutic treatments. Extrinsic factors
that contribute to skin compromise include immobility,
device related damage, extravasation wounds, and medical
adhesive related skin injury (MARSI), also known as
epidermal stripping.
Skin compromise is an inherent adverse event risk for
children in the Pediatric Intensive Care Unit (PICU) where
immobility, disease and/or illness and injury are common,
and optimal nutrition therapy is often a challenge. Point
prevalence survey studies report the incidence of PI in the
PICU population to range from 9% to 28% (6-8) and as
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high as 23% in neonates (9). Addressing skin compromise
in hospitalized children requires intentional focus and
multidisciplinary care. While optimal nutrition therapy
through provision of macronutrients is an important
consideration for wound healing and maintenance of skin
integrity, the role of micronutrient supplement therapy in
PI prevention and treatment is less well defined.
Recently published international clinical practice
guidelines identified suboptimal nutritional status as
a significant risk factor for PIs in adults (10). Though
these guidelines do not specifically address infants and
children, the authors infer similar assumptions for pediatric
patients. There is a dearth of information on the role of
micronutrients in prevention of PI and little guidance on
micronutrient supplementation therapy for PI management
in hospitalized pediatric patients. In this paper, we aim
to review the available literature related to PI in critically
ill children, identify best practice assessment tools to
identify PICU patients at risk for PI, describe macro and
micronutrient requirements in children in the PICU, and
discuss a multidisciplinary approach to the prevention,
identification and management of PI in critically ill pediatric
patients.
Methods
We performed a scoping review to characterize the
importance of nutrition status and therapy (including macro
and micronutrients) in the context of PI in hospitalized or
critically ill children. A scoping review was employed as
there is limited published literature on this topic. Scoping
reviews are an increasingly important methodology to
systematically explore and describe broad research topics,
and to set the stage for further, more specific investigations
such as systematic reviews (11). Scoping reviews differ from
other review methods in that they may accommodate and
include sources that are not empirical or have a rigorous
research methodology. Additionally, scoping reviews do
not perform critical appraisal or assessment on the selected
evidence. The PubMed, Embase, and CINAHL databases
were searched using keywords and index terms for elements
and nutrients of interest in a nutrition-related context. This
search was combined with searches for articles focused on
wounds or wound healing and limited to results from the
past ten years with pediatric patients as the focus or study
population. The search strategy used for this review is
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Table 1 Search strategy with mesh terms
Concept

Search Terms (Mesh & Keywords)

Results

1

Specified micronutrients (“zinc”[Mesh] OR "zinc"[all fields] OR "iron"[Mesh] OR “iron”[All Fields] OR
“selenium”[All Fields] OR “arginine”[Mesh] OR “arginine”[All Fields] OR “vitamin
A” OR “vitamin C” OR “ascorbic acid”[Mesh] OR “vitamin D”[Mesh] OR “vitamin
D”) AND ("Trace Elements" [Pharmacological Action] OR "Micronutrients"
[Pharmacological Action] OR "Trace Elements"[Mesh] OR “trace element*”[All
Fields] OR "Micronutrients"[Mesh] OR micronutrient*[All Fields])

304,608

2

Wounds healing

("Wound Healing"[Mesh] OR "wound healing"[All fields] OR “regeneration”[Mesh]
OR "wound care" OR “surgical wound”[Mesh] OR “pressure ulcer”[Mesh] OR
“pressure injury”[tiab] OR “wound assessment” OR “braden scale”)

277,548

1 AND 2

2,823

3
4

Date limit

AND ("2010/01/01"[PDat] : "2020/06/30"[PDat])

1,010

5

Children

AND ("infant"[MeSH Terms] OR "child"[MeSH Terms] OR "adolescent"[MeSH
Terms] OR children OR pediatric*)

130

6

Combined search

(“zinc”[Mesh] OR "zinc"[all fields] OR "iron"[Mesh] OR “iron”[All Fields] OR
“selenium”[All Fields] OR “arginine”[Mesh] OR “arginine”[All Fields] OR “vitamin
A” OR “vitamin C” OR “ascorbic acid”[Mesh] OR “vitamin D”[Mesh] OR “vitamin
D”) AND ("Trace Elements" [Pharmacological Action] OR "Micronutrients"
[Pharmacological Action] OR "Trace Elements"[Mesh] OR “trace element*”[All
Fields] OR "Micronutrients"[Mesh] OR micronutrient*[All Fields]) AND ("Wound
Healing"[Mesh] OR "wound healing"[All fields] OR “regeneration”[Mesh] OR
"wound care" OR “surgical wound”[Mesh] OR “pressure ulcer”[Mesh] OR
“pressure injury”[tiab] OR “wound assessment” OR “braden scale”) AND
(“2010/01/01”[PDat] : “2020/06/30”[PDat]) AND ("infant"[MeSH Terms] OR
"child"[MeSH Terms] OR "adolescent"[MeSH Terms] OR infant OR child OR
neonat* OR children OR pediatric*)

139

presented in Table 1.
Results
After the specified databases were searched and citations
identified, additional citations were added by hand searches
from published research known to the authors resulting
in a combined total of 553 articles. Once duplicate articles
were removed, two authors (KB, SS) then screened citations
by title and abstract according to broad characteristics of
language, publication type, and population (n=528). The
retained citations were subsequently screened according
to exclusion and inclusion criteria developed by the
research team. Eligible citations were acquired in full text
and distributed to all authors for review and synthesis.
Figure 1 is the PRISMA flow diagram of the article selection
process. In total, we reviewed 82 full text articles to develop
this narrative, what follows is a summary of macro and
micronutrients in the context of pediatric critical illness.

© Translational Pediatrics. All rights reserved.

Energy
Estimated energy needs should account for the
hypermetabolic state of the hospitalized patient as well
as the need for anabolic cell regeneration to heal injured
tissue (12). Adequate energy delivery is needed to maintain
positive energy balance to enable protein utilization for
collagen and nitrogen synthesis, rather than its breakdown
for energy. When the body is depleted of carbohydrate and
fat sources, the liver and kidneys turn to utilizing protein
from muscle degradation to metabolize lean body mass into
glucose (13). Subsequently, there is less available protein to
support the anabolic process of wound healing. Although
no published data to date gives specific energy requirements
for PI healing in critically ill children, increases in energy
and protein provisions have been shown to be beneficial for
wound healing in adult populations (10,14,15).
Pre-existing malnutrition, inclusive of obesity, should
be taken into consideration when estimating total energy
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Identification

PRISMA 2009 Flow Diagram

Records identified through

Additional records identified

database searching

through other sources

(n=404)

(n=149)

Screening

Records after duplicates removed (n=528)

Records excluded

(n=528)

(n=68)

Included

Eligibility

Records screened

Full-text articles assessed for

Full-text articles

eligibility

excluded, with reasons

(n=460)

(n=378)

Studies included in qualitative
synthesis
(n=82)

Figure 1 Prisma flow diagram for article screening and inclusion.

needs. Protein-energy malnutrition increases risk for
developing PI and impairs wound healing. Children
presenting in a malnourished state require higher total
energy provision than what is recommended for wellnourished children. In-depth nutrition assessment by a
registered dietitian (RD) is an important step to determine
energy and protein needs to support catch-up growth and
wound healing (16). Ensuring timely and optimal delivery
of energy to children with PI is important, however rapid
increases in energy delivery should be weighed against the
risks of electrolyte imbalances that can occur with refeeding
syndrome (17).
Protein
Protein is needed for maintenance of skin integrity, growth
© Translational Pediatrics. All rights reserved.

and proliferation of cells, and for fluid and electrolyte
balance (18). It has been suggested that the presence of a
stage 1-3 PI and/or deep tissue injury (DTI) increases the
protein requirement above the U.S. Recommended Daily
Allowance (RDA) (10,19). Additionally, the most severe PI
(stage 4), have the greatest protein needs for healing (20).
Critically ill children in general have increased protein
requirements compared to their healthy counterparts, the
presence of a PI can further increase these needs. The
pediatric critical care nutrition guidelines set forth by the
American Society for Parenteral and Enteral Nutrition
(ASPEN) and the Society of Critical Care Medicine
(SCCM) do not recommend using the RDA for protein as it
often underestimates the needs of critically ill children (21).
When increasing protein delivery, comorbidities affecting
protein metabolism and utilization such as acute kidney
Transl Pediatr 2021;10(10):2799-2813 | https://dx.doi.org/10.21037/tp-21-3
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injury and other organ dysfunction must be taken into
consideration.
Fat
Adequate fat delivery is important to prevent micronutrient
deficiencies that can alter skin integrity. Fat is the most
concentrated source of energy and can be stored as
triglycerides in adipose tissue for later use. Adequate
delivery of essential fatty acids (alpha-linolenic and
linoleic fatty acids) is important to prevent micronutrient
deficiencies that can alter skin integrity (22). Signs of
essential fatty acid deficiency include xerosis, seborrheic
dermatitis, and poor wound healing (22-24). Fat in the diet
is also needed to aid absorption of fat-soluble vitamins A,
E, D, and K. Fat should account for a minimum of 10−25%
of overall energy intake, and include essential fats, linolenic
and linoleic acid, to avoid deficiency.
Fluid
Dehydration impairs oxygen delivery to wounded tissue.
Stage 1–2 pressure ulcers do not typically necessitate
increased fluid requirements above maintenance. However,
in adults, fluid needs are increased due to increased
insensible losses through wound drainage (10). If a wound
drainage device is used, losses from drainage output should
also be taken into consideration when assessing fluid status.
It is important to manage the fluid needs of critically ill
children based on their clinical status as it can be highly
variable between patients. It is especially important to
prevent worsening fluid overload as patients often receive
significant volume resuscitation early in their ICU course
that can impact clinical outcomes.
Zinc
Zinc is an essential mineral that plays a vital role in
wound healing, cell division, immune function, and
synthesis of DNA and RNA (25). Causality for zinc
deficiency can be varied, Corbo et al. (2013) proposed an
etiologic classification system of five broad categoriestype I inadequate intake, type II excessive losses, type III
malabsorption, and type IV increased demand, and type
V other (26). Zinc deficiency can manifest in numerous
ways given its various functions in the body’s organ
systems. Signs and symptoms of zinc deficiency include,
but are not limited to, stunting, altered taste and smell,
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impaired wound healing, and hypogonadism. Specific
cutaneous presentation with zinc deficiency includes skin
lesions (typically crusted plaques of perianal and perioral
areas), alopecia, and diarrhea (27). Zinc levels used in
conjunction with a skin assessment and history help
confirm a zinc deficiency. However, zinc levels can be
falsely low in times of acute stress and inflammation (26).
Therefore, clinical status should be considered when
assessing zinc levels, especially in critical illness, and
attention should be paid to significant wound drainage or
gastrointestinal losses that can increase zinc losses. If zinc
deficiency is identified, supplementation with zinc should
be initiated. Clinical remission often begins within days
of treatment initiation (28). Individuals should not stay
on oral zinc supplementation for a prolonged duration as
zinc competes with copper absorption. This negatively
impacts copper levels which can be counterproductive to
wound healing as copper is a necessary cofactor in collagen
cross-linking (29). Zinc toxicity is rare, but excessive intake
may cause GI distress (30).
Zinc is an important factor in wound healing. Adult
studies have shown that zinc supplementation can improve
wound healing, but only in patients with deficient levels
(29,31,32). Pediatric studies are lacking. Therefore, routine
zinc supplementation is not recommended, unless deficiency
is observed. Extrapolation of adult studies to the pediatric
population is unclear, and more research is needed to better
understand and determine zinc supplementation in wound
healing particularly in PI in children.
Vitamin C
Vitamin C is a water-soluble vitamin that functions as
an antioxidant, and a cofactor for several enzymes. It
plays a key role in fatty acid transport, collagen synthesis,
neurotransmitter synthesis, prostaglandin metabolism,
and nitric oxide (NO) synthesis (33). Risk factors for
deficiency in pediatric patients are developmental delay
and autism (due to selective or limited diets), iron overload,
periods of oxidative stress, and chemotherapy. Signs of
deficiency include poor wound healing, musculoskeletal
and joint pain, lethargy, weakness, anorexia, edema,
depression, neuropathy, and vasomotor instability. Scurvy
is a manifestation of vitamin C deficiency and can present
as perifollicular hemorrhage, petechiae, coiled hair,
gingivitis, ecchymosis, mucosal bleeding, and anemia (33).
Deficiency from poor intake can occur in as little as three
months, though in critically ill children a deficiency may
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occur sooner due to oxidative stress (34). No recommended
treatment doses for vitamin C exist for pediatric patients
with wounds or PIs. Vitamin C toxicity is rare, however
gastrointestinal upset and oxalate stones have been reported
in adults with kidney disease (35).
Vitamin A
Vitamin A is a fat-soluble vitamin and a potent antioxidant.
Vi t a m in A p la ys a ro l e i n ma ny b o d i l y fu n ction s
including bone health, gene transcription, cell and tissue
differentiation, mucous membrane integrity, collagen
synthesis, and immune function (36). With respect to skin
integrity and wound healing, vitamin A deficiency can result
in impaired healing and increased susceptibility to wound
infections. There is no recommended Vitamin A dosing
available for wound healing in pediatric patients. Vitamin
A should be dosed cautiously in individuals with liver and/
or renal impairment. Acute toxicity in adults with single
dosing >150,000 mcg has been reported to cause nausea,
vomiting, headache, vertigo, blurred vision, and increased
intracranial pressure (37). Additionally, in infants, a bulging
fontanel has been reported in acute and chronic toxicity
(38,39). Chronic toxicity in adults who are supplemented
with more than 30,000 mcg over an extended period of
time can cause irritability, anorexia, skin desquamation, and
biochemical liver abnormalities (elevated enzymes, fibrosis,
and cirrhosis). Additional abnormal findings observed
with vitamin A toxicity in infants include hypercalcemia,
hyperphosphatemia, and metastatic calcifications which
can occur with intakes of 5,500–6,750 mcg/d or more
for an extended time of 1–3 months (38). Therefore,
chronic supplementation with Vitamin A is not typically
recommended and should be monitored closely with blood
levels.
Iron
Iron is a mineral that plays an essential role in skin health,
mucous membrane integrity, hair, and nails. Iron, along with
vitamin C, is needed for collagen synthesis, and is critical
for red blood cell production. Clinically, iron deficiency can
present as skin pallor, angular cheilitis, koilonychia (spoon
nails), fragile nails, pruritus, and brittle hair. Pediatric
patients (6–20 months of age) are at risk for iron deficiency
anemia, as they transition from iron-fortified formula to
cow’s milk. Additionally, females are at increased risk for
iron deficiency secondary to iron losses with menstruation.

© Translational Pediatrics. All rights reserved.
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An iron profile is often used to diagnose iron deficiency.
However, it should be noted that ferritin, a component of
the iron profile, is an acute phase reactant and not reliable
in the critically ill patient.
With regards to skin function and integrity, iron
deficiency anemia may negatively impact wound strength,
but this has not been consistently demonstrated in available
human studies (40-42). Thus far, these studies have yet
to demonstrate the effects of iron deficiency anemia on
the stages of wound healing, with even less available
information related to the interplay of iron and PI. There
are no current guidelines related to optimum iron dosing
for wound healing in pediatric patients. However, if
iron deficiency is present, an iron-rich diet and/or iron
supplementation is warranted. To enhance absorption, iron
should be taken enterally with foods rich in vitamin C.
Arginine
Arginine is considered a conditionally essential amino acid,
which means that in times of acute stress or trauma, the
body is unable to produce adequate amounts of arginine to
keep up with the physiologic demands (43). Arginine plays
a role in collagen synthesis and has immune modulating
properties, both of which may contribute to wound
healing. Adult studies investigating the use of oral nutrition
supplements (ONS) enriched with arginine, zinc, and
antioxidants have shown a positive increase in the rate of
healing (14,18,44,45). Isolated arginine supplementation is
not standard clinical practice, particularly given concerns of
its potential to cause excessive nitric oxide (NO) production
in critically ill patients with resulting harm (46).
Proposed nutrition management for children
with PIs
Currently, there are no published practice or clinical
guidelines for optimum nutrition therapy in pediatric
patients with varying stages of PIs. In addition, there are
no nutrition risk assessment screening tools validated in
critically ill pediatric patients. Thompson et al. addresses
nutrition interventions to optimize pediatric wound healing;
however, they do not specifically address PIs in critically ill
children (47). The clinical pathway developed by Thompson
et al. (2014), is to optimize nutrition therapy in pediatric
patients with wounds. These authors included wounds
that were non-healing surgical incisions, dehisced surgical
sites, PIs staged 2–4, wounds requiring wound vac devices,
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and skin breakdown secondary to infections, and nutrition
deficiencies (47). Notably, the authors reported increased
identification of micronutrient deficiencies (specifically
vitamin C and zinc) as well as improved monitoring of
patient’s nutritional status in their institution following
implementation of the clinical pathway (47). The pathway
also allowed for a standardized approach among clinicians
to manage nutrition therapy for patients with wounds as
identified above.
It is unclear when inadequate nutritional intake begins to
negatively affect skin integrity. However, inadequate intake
of both macro and micronutrients have a known association
with impaired wound healing (10). The increased
nutrient needs of pediatric patients to meet the metabolic
requirements of age appropriate growth, may be further
increased with the presence of PIs, making it imperative to
adjust nutrition therapy to support both the basic metabolic
requirements and adequate wound healing. This becomes
particularly challenging in the hospitalized or critically
ill child who often have additional clinical management
priorities that potentially compete with nutrition therapy.
Table 2 lists proposed modifications for both macro and
micronutrients based on PI staging. Our group developed
this proposed table with data modeled from ASPEN’s
available adult data and is intended for use with children
who weigh less than 30 kilograms. The goal of the table
is to offer guidance for clinicians to assess, treat, and
monitor deficiencies aligned with wound and PI treatment.
The tolerable upper limit for vitamin and mineral intake
significantly increases from age 4−8 years to that of 9−13
years; therefore, the age of 9 years was used as a cutoff.
With no currently available guidelines, the authors chose
the 50th percentile for weight in 9-year-old as a point of
reference to determine the corresponding weight cut-off
limit. A 30 kg cutoff was determined as this is the weight at
approximately the 50th percentile for both 9-year-old boys
and girls identified on the Centers for Disease Control
(CDC) growth chart for 2- to 20-year-old children.
As with any nutrition intervention, it is imperative
to consider the child’s medical history and adjust their
macro and micronutrient intake based on disease state
and the child’s nutrition status guided by anthropometric
measurements obtained at admission. For example, in
patients with cholestatic liver disease, careful choosing of
an appropriate multivitamin product is necessary due to
malabsorption of fat-soluble vitamins in this population
Additionally, Table 3 lists initial doses as well as a subsequent
schedule for micro-nutrient monitoring of vitamins and
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minerals that are essential for adequate wound healing. The
table provides proposed lab monitoring frequency and a
suggested adjustment of micro-nutrient supplementation
based on laboratory measurements. For example, after
initiating zinc supplementation at 1 mg/kg/day for a low
level, if the laboratory value remains deficient on repeat
assessment 4 weeks after supplement initiation, the dose
should be increased with a plan to reassess at specified
intervals. As with all nutrient supplementation, it is
important to consider the individual as a whole and take
into consideration any underlying organ dysfunction that
may interfere with absorption or utilization, while being
cognitive of the tolerable upper limits of supplementation
for age.
Multidisciplinary team approach
Role of the clinical nurse
Routine and thorough skin assessments begin with
the patient’s nurse, is shared between all members of
the clinical team and are crucial in PI prevention and
management in pediatric patients. Prevention of PIs starts
with a thorough assessment of the patient and their skin
integrity upon admission and continues routinely at serial
intervals to identify injuries and accurately determine
the risk of developing a hospital-acquired PI (53). These
evaluations range from detailed physical assessment to
review of medical records and include identification and
stratification of risk (53). Risk assessments are performed
at a frequency based on unit standards, patient diagnosis,
acuity, mobility and, other aspects of the patient’s condition
that may predispose them to a PI (53). If concerns for skin
integrity are present, a Skin Champion, a specially trained
clinical nurse is consulted to further review the extent of
injury. They extend the assessment to include areas where a
medical device is in constant contact with the skin. The goal
of these assessments is to identify areas that raise concern
for development of PI.
Role of the certified wound, ostomy, continence nursing
(CWOCN) specialist
Once a wound or significant skin injury is identified, a
CWOCN specialist joins the clinical team for a more
specialized skin injury assessment and staging. The
CWOCN specialist then makes further recommendations
for wound care with the clinical team. Combined with the
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Stage 4: Full-thickness skin
15–30% higher
and tissue loss with exposed or
directly palpable fascia, muscle,
tendon, ligament, cartilage or
bone in the ulcer

Stage 4, large,
multiple and/or
draining ulcer and/
or moderate-severe
catabolic state

RDA × 2–2.5

RDA × 1.5–2

RDA × 1.5–2

RDA × 1.5–2

Protein

Maintenance x
1–1.15

Maintenance x
1–1.15

Maintenance

Maintenance

Fluid

Give multivitamin
with minerals

Give multivitamin
with minerals

If diet not meeting
80% of RDA/DRI
give multivitamin
with minerals

If diet not meeting
80% of RDA/DRI
give multivitamin
with minerals

Multivitamin***

62.5–100 mg/day

62.5–100 mg/day

Check level first

Check level first

Vitamin C

1 mg/kg/day
divided in
1–3 doses

1 mg/kg/day
divided in
1–3 doses

Check level
first

Check level
first

Zinc

Check
level first

Check
level first

Check
level first

Check
level first

Vitamin
A**

*, Baseline calorie needs should be estimated per the institutions standards of care and clinician judgement. **, Vitamin A should be dosed cautiously in liver and kidney
disease. ***, Multivitamin products should be chosen and adjusted for underlying organ dysfunction. Reproduced from abstract (48).

Unstageable: Full thickness
skin and tissue loss in which
the ulcer is covered by slough
or eschar

DTI-deep tissue injury or non0–15% higher
intact skin with localized area
of persistent non-blanchable
deep red, maroon, purple
discoloration or epidermal
separation revealing a dark
wound bed or blood filled blister
Stage 3: full thickness loss of
skin, in which adipose is visible
in the ulcer and granulation
tissue are often present. Fascia,
muscle, tendon, ligament,
cartilage and/or bone are not
exposed

Stage 3, small
nondraining ulcers
and or only mild
catabolic state

0–15% higher

Stage 1and 2:
Stage 1: non blanchable
Moderate to severe erythema, skin intact
catabolic state
Stage 2: partial thickness
wound or fluid filled blister

Calories
Normal*
(based on
age, sex, and
activity)

Wound description

Stage 1 and 2, mild Stage 1: non blanchable
catabolic state
erythema, skin intact
Stage 2: partial thickness
wound or fluid filled blister

Stage

Table 2 Proposed macro and micronutrient management for pediatric patients <30 kg based on pressure injury staging
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62.5–100 mg
daily*

1 mg/kg*

Vitamin C

Zinc

Enteral or IV

Enteral or IV

Route

N/A
Check at time of
initiation then every
4 weeks

Stable or not
healing

Check at time of
initiation then every
4 weeks

Stable or not
healing

Improved

N/A

Lab monitoring

Improved

Wound
assessment

N/A

N/A

Arginine

Iron

N/A

N/A

N/A

Not healing

Not healing

Not healing

N/A

Start enteral iron
supplementation
1–2 mg/kg/dose*
(max dose 300 mg)

0–6 mo: 4 mg;
7–12 mo: 5 mg;
1–3 y: 7 mg;
4–8 y: 12 mg;
9–13 y: 23 mg

1–3 y: 400 mg;
4–8 y: 650 mg;
9–13 y: 1,200 mg

Tolerable upper limit
(TUL)**

Birth–13 y: 40 mg

N/A

Early: sparse coarse Birth–3 y: 600 mcg;
hair, dry rough skin, 4–8 y: 900 mcg;
dry eyes, cracked
9–13 y: 1,700 mcg
lips
Late: headache,
generalized
weakness, pruritus,
anorexia, bone
pain, hepatomegaly,
splenomegaly

Early: Nausea,
vomiting, diarrhea,
headache
Chronic: can lead
to copper or iron
deficiency

Rare but can
include: diarrhea,
nausea, occult
rectal bleeding,
renal colic

Consider using
N/A
arginine based
enteral formula or oral
nutrition supplement
for 4 weeks

Increase total vitamin
A dose by changing
formula or adjusting
multivitamin product

Continue supplement
and consider
increasing the dose if
able

Deficient

Deficient

Discontinue
supplement

Sufficient or
elevated

Discontinue
supplement

Increase dose by
50%

Deficient
N/A

Discontinue
supplement

Discontinue
supplement

Signs and
Duration of therapy or
symptoms of
nutrient adjustments
toxicity:

Sufficient or
elevated

N/A

Lab value
interpretation

Check iron panel and Deficient
ferritin

N/A

Check level

Dosing adapted from *references (49-51) and TUL from **reference (52).

N/A

Vitamin A

Consider these additional nutrients if wound is not healing as expected

Initial dose

Nutrient

Table 3 Vitamin and mineral supplementation and laboratory monitoring recommendations for pediatric patients with pressure injuries
Translational Pediatrics, Vol 10, No 10 October 2021
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RN completes for all inpatients:
• Braden QD
• Head to toe skin assessment every shift
• Position changes every 2 hours
• Documents in electronic health record (EHR)
lf a skin injury is noted:
• Contact unit skin champion
• Apply skin medications and complete dressing
changes as ordered
• Documents skin injury in EHR and notify medical
team

“Skin Champion” is a RN with training for
pressure injury prevention for their unit.
• Completes weekly pressure injury rounds to look
for new injuries
• Collaborates with bedside RN to make a
treatment plan for stage 1-2 injuries usually
consists of offloading, silicone dressing, specialty
bed, etc)
• Places wound consult for more concerning
injuries (i.e. complicated stage 2 and above,
including DTI)
Bedside
RN

RN Skin
Champion

Patien

RD
Registered Dietitian
• Complete full nutrition assessment on admission
and then weekly
• Evaluate malnutrition status
• Monitor anthropometrics
• Develop and adjust nutrition interventions (i.e.
macro and micronutrients) based on wound
assessment and clinical status
• Develop lab monitoring plan

Wound
Consult

Certified Wound, Ostomy, and Continence Nurse
(CWOCN)
• Complete full wound assessment for patients
with stage 3, stage 4, DTl, and possibly more
complicated stage 2 injuries
• Follow patients with no injury that are at HlGH
risk for developing an injury (i.e. ECMO)
• Complete complicated dressing changes (i.e.
fistulas and wound vacs)
• Upload pictures of wound in EHR
• Document recommendations including nutrition
consult

Figure 2 Multidisciplinary team approach to pressure injury prevention and managemen

medical care team, this multidisciplinary approach ensures
engagement of the entire team, all focused on keeping
the patient and/or family at the forefront of care delivery.
Figure 2 illustrates a proposed model for multidisciplinary
engagement.
Assessment of patients at risk—Braden QD scale
Hospitalized infants and children are at risk for PI, and may
possess both intrinsic and extrinsic factors for developing
wounds and skin compromise. The child with autoimmune
and genetic skin conditions (e.g., pyoderma gangrenosum
or epidermolysis bullosa), immunocompromised state
(e.g., graft versus host disease, GVHD), requiring surgical
intervention, or undergoing therapeutic treatment with
potential for skin breakdown (e.g., radiation therapy) have
intrinsic factors increasing the risk for PI. Extrinsic factors
are additive to the intrinsic factors and increase the risk

© Translational Pediatrics. All rights reserved.

of the already physiologically compromised child for skin
damage or PI that can further complicate their care. Table 4
describes PI with staging.
The Braden Q scale adapted from the Braden Scale (55)
is one of the most widely used and is currently the most
inclusive scale for measuring risk of PI in the pediatric
population (56). In addition to the six original subscales
(mobility, activity, sensory perception, moisture, friction
and shear, nutrition) from the original Braden Scale, the
Braden Q scale adds parameters for tissue perfusion/
oxygenation. The Braden Q scale has given way to the
revised Braden QD scale (5). Tested on a broader age range,
from pre-term to 21 years of age, the Braden QD scale
also includes patients with cardiac disease and those in a
non-critical care environment. Additionally, the Braden
QD scale includes numerical scoring to identify the risk of
PI from medical devices (47). In hospitalized infants and
children, MDRPI is reported to account for up to 71 % of
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Table 4 Pressure injury staging and definitions (54)
Pressure injury staging

Definitions

Stage 1 Pressure Injury

Non-blanchable erythema of intact skin
Intact skin with a localized area of non-blanchable erythema, which may appear differently in darkly
pigmented skin. Presence of blanchable erythema or changes in sensation, temperature, or firmness may
precede visual changes. Color changes do not include purple or maroon discoloration; these may indicate
deep tissue pressure injury

Stage 2 Pressure Injury

Partial-thickness skin loss with exposed dermis
The wound bed is viable, pink or red, moist, and may present as an intact or ruptured serum-filled blister.
Adipose (fat) is not visible and deeper tissues are not visible. Granulation tissue, slough and eschar are not
present. These injuries commonly result from adverse microclimate and shear in the skin over the pelvis
and shear in the heel. This stage should not be used to describe moisture associated skin damage (MASD)
including incontinence-associated dermatitis (IAD), intertriginous dermatitis (ITD), medical adhesive related
skin injury (MARSI), or traumatic wounds (skin tears, burns, abrasions)

Stage 3 Pressure Injury

Full-thickness skin loss
Full-thickness loss of skin, in which adipose (fat) is visible in the ulcer and granulation tissue and epibole
(rolled wound edges) are often present. Slough and/or eschar may be visible. The depth of tissue damage
varies by anatomical location; areas of significant adiposity can develop deep wounds. Undermining and
tunneling may occur. Fascia, muscle, tendon, ligament, cartilage and/or bone are not exposed. If slough
or eschar obscures the extent of tissue loss this is an Unstageable Pressure Injury

Stage 4 Pressure Injury

Full-thickness skin and tissue loss
Full-thickness skin and tissue loss with exposed or directly palpable fascia, muscle, tendon, ligament,
cartilage or bone in the ulcer. Slough and/or eschar may be visible. Epibole (rolled edges), undermining
and/or tunneling often occur. Depth varies by anatomical location. If slough or eschar obscures the extent
of tissue loss this is an Unstageable Pressure Injury.

Unstageable Pressure Injury

Obscured full-thickness skin and tissue loss
Full-thickness skin and tissue loss in which the extent of tissue damage within the ulcer cannot be
confirmed because it is obscured by slough or eschar. If slough or eschar is removed, a Stage 3 or
Stage 4 pressure injury will be revealed. Stable eschar (i.e., dry, adherent, and intact without erythema or
fluctuance) on the heel or ischemic limb should not be softened or removed

Deep Tissue Pressure Injury

Persistent non-blanchable deep red, maroon or purple discoloration
Intact or non-intact skin with localized area of persistent non-blanchable deep red, maroon, purple
discoloration or epidermal separation revealing a dark wound bed or blood filled blister. Pain and
temperature change often precede skin color changes. Discoloration may appear differently in darkly
pigmented skin. This injury results from intense and/or prolonged pressure and shear forces at the bonemuscle interface. The wound may evolve rapidly to reveal the actual extent of tissue injury, or may resolve
without tissue loss. If necrotic tissue, subcutaneous tissue, granulation tissue, fascia, muscle or other
underlying structures are visible, this indicates a full thickness pressure injury (Unstageable, Stage 3 or
Stage 4). Do not use DTPI to describe vascular, traumatic, neuropathic, or dermatologic conditions

Additional pressure injury definitions
Medical device related
pressure injury

This describes an etiology. Medical device related pressure injuries result from the use of devices designed
and applied for diagnostic or therapeutic purposes. The resultant pressure injury generally conforms to the
pattern or shape of the device. The injury should be staged using the staging system

Mucosal membrane pressure
injury

Mucosal membrane pressure injury is found on mucous membranes with a history of a medical device in
use at the location of the injury. Due to the anatomy of the tissue, these ulcers cannot be staged

© Translational Pediatrics. All rights reserved.
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HAPI (57-60). Identifying PI risk from devices is crucial in
the PICU population, where the use of complex medical
technology is an integral component of care delivery. The
Braden QD scale is validated in the hospitalized pediatric
population showing sensitivity of 0.86 (95% CI: 0.76–0.92)
and specificity of 0.59 (95% CI: 0.55–0.63) (5). It is the only
PI risk scale to include medical devices as a potential hazard
for occurrence of PI in adult and pediatric populations, and
has a nutritional sub-score to determine current nutrition
status. The Braden QD scale facilitates the identification
of patients at risk for developing PI early in hospitalization
allowing for timely delivery of quality, multi-disciplinary
patient centered care.
Role of the RD
Nutrition status at the time of hospitalization is believed
to have significant impact on the hospitalized and critically
ill pediatric patient and their risk for PI. Patients who
present with protein-energy malnutrition on admission
are at significant risk for delayed wound healing. Healing
requires an optimal nutrition status as wounds lead to a
catabolic state which then significantly increase nutritional
demands (15). When the body is faced with the added
burden of wound healing in the presence of malnutrition it
begins to break down lean body mass for protein which then
in turn delays the onset of healing. Nutrient deficiencies
increase the risk of developing a PI, therefore a nutritional
plan inclusive of necessary supplementation for at risk
patients should be executed under the direction of a RD (61).
The RD is uniquely qualified in many ways to serve as
an integral member of the clinical care team. The expertise
of a RD to perform a nutritional assessment within the
initial 48 hours of PICU admission can help identify
nutritional pitfalls, sub-optimal nutrition status, and
patients at increased risk for PI early in the hospital stay (61).
Nutrition assessment includes determining the patient’s
needs and goals for macronutrients and micronutrient
supplementation specific to wound healing. These
assessments should then continue to be performed weekly
after admission to re-evaluate the patient throughout the
course of their PICU stay (61). Following a thorough
assessment, the RD can recommend an appropriate oral,
enteral, parenteral or combined regimen to meet the
patient’s identified nutritional goals.
Working with the family, incorporating home food
preferences (where appropriate), the RD is integral in
keeping the patient and family involved, and in the forefront
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while devising a nutrition therapy plan of care appropriate
for the patient’s clinical illness status and the mode by which
the nutritional plan will be delivered. Working with the
clinical staff, the RD will incorporate potential interruptions
in nutrient delivery to create a reliable and achievable
feeding plan for use in the hospital and potentially in the
home setting. Diet modification is directed by the RD
as necessary to accommodate for food allergies, cultural
dietary customs, dietary preferences such as vegetarianism,
and health conditions such as diabetes, obesity or kidney
disease that require a specific therapeutic diet to optimize
established guidelines necessary for wound healing. In
addition, the clinical RD is knowledgeable about the
availability of protein and/or calorie modular supplements
commercially available, or able to be created with
household ingredients per patient and family preference. In
addition, the RD can assess vitamin and mineral laboratory
measurement data and recommend supplementation and
monitoring where appropriate to enhance wound healing.
If the oral route is not sufficient to meet the patient’s
increased energy and protein needs prescribed by the RD,
supplemental tube feedings may then be recommended.
This can be provided via an enteral feeding tube. The
patient’s family can also be advised (by the clinical team)
to consider semi-permanent enteral access such as a
percutaneous gastrostomy (PEG) tube to ensure adequate
nutrition intake if oral intake cannot be maintained to
support nutritional needs, and skin integrity. Development
of multiple or chronic pressure injuries increase risk of
infection, arthritis and osteomyelitis, leading to sepsis and
possibly death. RDs possess the knowledge and skills to
translate the recent research into clinical practice.
Limitations
There are limitations to this work to be acknowledged.
There is a significant void in the literature giving guidance
for optimal nutrition therapy for pediatric patients with or
at risk for PI wound care of device induced skin injury. The
scoping review performed was limited to recent literature
in the last ten years, however, lacks definitive evidence or
guidelines to inform nutrition therapy or supplementation
specific to this population of patients. While the
recommendations given are useful to our institution, a
large quaternary-care, urban, academic children’s hospital,
they may not be the same resources available in other
institutions. Future work should entail close monitoring
of nutrition therapy, micronutrient supplementation and
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laboratory monitoring to establish efficacy and determine
impact on patient outcomes. Research and review are
urgently needed.
Conclusions
There is a substantial gap in knowledge and research in how
nutrition therapy influences PI healing in pediatric patients.
Hospitalized children, especially critically ill children, are
at increased risk of PI development. Suboptimal nutrition
status can impair, and delay wound healing, and attention
should be paid to macro and micronutrient intake.
Nutrition status plays a critical role in wound healing, and
children have unique needs given their increased metabolic
demands compared to adults. These proposed initial
recommendations for assessing children with PI are meant
to ensure adequate nutritional therapy to optimize wound
healing. However, research to further build upon these
recommendations is necessary to better define the role of
nutrition therapy and supplementation in PI prevention and
healing among hospitalized children.
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